ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)

10.04.2023 - FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) - via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that ... Seite 1

Related Keywords

,Howard Doong ,Scott Irwin ,Sinai Samuel Oschin Comprehensive Cancer Institute ,Sinai Medical Center ,Initiation Visit ,Cedars Sinai Medical Center ,Chief Executive Officer ,Montgomery Asberg Depression Rating Scale ,